Comments
Loading...

Cyclacel Pharmaceuticals

CYCCNASDAQ
Logo brought to you by Benzinga Data
$1.04
-0.03-2.34%
At Close: -
$1.03
-0.01-1.44%
After Hours: Sep 16, 9:28 AM EDT
15 minutes delayed

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock, Earnings Estimates, EPS, And Revenue

Cyclacel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 14
EPS
$-0.720
Quarterly Revenue
$4K
Annual Revenue
(as of Jun 30)
$80K

Analyze the earnings history of Cyclacel Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Cyclacel Pharmaceuticals (CYCC) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-14$-0.72$-1.4349.6 %
Mar 20242024-05-14$-2.27$-4.7452.1 %
Dec 20232024-03-19$-6.23$-5.89-5.77 %
Sep 20232023-11-13$-7.35$-5.40-36.1 %

Cyclacel Pharmaceuticals (CYCC) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-14$4.00K$30.00K-86.7 %

FAQ

Q

When is Cyclacel Pharmaceuticals (NASDAQ:CYCC) reporting earnings?

A

Cyclacel Pharmaceuticals (CYCC) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)?

A

The Actual EPS was $-0.72, which beat the estimate of $-1.43.

Q

What were Cyclacel Pharmaceuticals’s (NASDAQ:CYCC) revenues?

A

The Actual Revenue was $4K, which missed the estimate of $30K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch